SOBRsafe Inc. (NASDAQ: SOBR) Announces New Four-Facility Contract Adding to a Significant Increase in New Clients

  • SOBRsafe, providing the latest in transdermal alcohol detection solutions, has signed another new customer, one that provides full continuum care, from inpatient detox and residential treatment to outpatient services, and has now installed SOBRcheck(TM) in each of its four facilities to enable point-of-care screening
  • The customer is also evaluating SOBRsafe’s wearable band, SOBRsure(TM), for continuous monitoring in an outpatient application
  • The new Florida client is one of sixteen new accounts that SOBRsafe secured during the first quarter of 2024
  • The global alcohol sensor market was valued at $2.3 billion in 2022 and is expected to grow at a CAGR of 13.7%, resulting in a value of $6.3 billion by 2030

SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that they have signed a hardware/software agreement with a four-facility behavioral health provider based in Florida. (https://ibn.fm/7cxba).

The customer provides the full continuum of care, from inpatient detox and residential treatment to outpatient services, and has now installed SOBRcheck(TM) in each of its four facilities to enable point-of-care screening. The customer is also evaluating SOBRsafe’s wearable band, SOBRsure(TM), for continuous monitoring in an outpatient application.

The new client is one of sixteen new accounts that SOBRsafe secured during the first quarter of 2024. These new accounts represent a jump in growth for the company, driven by products that offer non-invasive, efficient, hygienic and connected alcohol detection solutions that legacy alcohol detection technologies can’t match.

The global alcohol sensor market was valued at $2.3 billion in 2022 and is expected to grow at a CAGR of 13.7%, resulting in a value of $6.3 billion by 2030 (https://ibn.fm/jRJbc). Factors fueling market growth include rising alcohol consumption rates, stricter laws pertaining to alcohol consumption, and more effective technologies that facilitate detection and enforcement.

SOBRsafe currently offers the following products to help with alcohol detection in the behavioral health and justice sectors:

  • SOBRsafe(TM): Committed to its mission of preserving lives, enhancing productivity, generating significant economic advantages, and fostering positive behavioral change, SOBRsafe has developed the patent-pending SOBRsafe platform. This platform enables non-invasive alcohol detection, real-time reporting, and historical data aggregation on a scalable level. SOBRsafe offers a versatile solution applicable across various sectors including behavioral health, fleet and facility safety, youth drivers, and judicial markets.
  • SOBRcheck(TM): SOBRcheck represents the company’s stationary identification and alcohol monitoring solution, delivering swift, targeted alcohol tests at specific points in time. In a hygienic and real-time manner, SOBRcheck authenticates user identity while determining alcohol presence or absence. SOBRcheck delivers immediate results securely to administrators, aiding in the effective management of existing substance abuse policies.
  • SOBRsure(TM): SOBRsure introduces the company’s transdermal wearable for alcohol detection. Providing continuous mobile alcohol monitoring, SOBRsure discreetly identifies alcohol presence in the body in real-time. SOBRsure also offers app-based alcohol detection alerts, precise location tracking, and notifications for band removal.

SOBRsafe Director of Commercial Development Eddie Kilroy, said the new Florida customer historically used breathalyzers for select check-ins, but felt these legacy devices were too inefficient and invasive for uniform entry screening. “With SOBRcheck, the provider can verify the absence of alcohol in just 10 seconds or less, in a humane and cost-effective manner. The customer is streamlining operations with automatic results reporting, and electronic records searchable by individual and location,” Kilroy explained. “Switching to SOBRcheck has empowered them to enhance and expand their screening protocols, while likely reducing attempts to subvert the testing process.”

For more information, visit the company’s website at www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
Editor@TechMediaWire.com

TechMediaWire is powered by IBN

Archives

Select A Month

Contact us: (310) 299-1717